Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Aker BioMarine ASA's Total Stockholders Equity for the quarter that ended in Mar. 2024 was kr3,763 Mil. Aker BioMarine ASA's Total Assets for the quarter that ended in Mar. 2024 was kr8,633 Mil.
Therefore, Aker BioMarine ASA's Equity to Asset Ratio for the quarter that ended in Mar. 2024 was 0.44.
The historical rank and industry rank for Aker BioMarine ASA's Equity-to-Asset or its related term are showing as below:
OSL:AKBM'
s Equity-to-Asset Range Over the Past 10 Years
Min: 0.22 Med: 0.48 Max: 0.53
Current: 0.44
During the past 12 years, the highest Equity to Asset Ratio of Aker BioMarine ASA was 0.53. The lowest was 0.22. And the median was 0.48.
OSL:AKBM's Equity-to-Asset is ranked worse than 63.3% of 1921
companies
in the Consumer Packaged Goods industry
Industry Median: 0.54
vs OSL:AKBM: 0.44
Aker BioMarine ASA Equity-to-Asset Historical Data
The historical data trend for Aker BioMarine ASA's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Aker BioMarine ASA's Equity-to-Asset
For the Packaged Foods subindustry, Aker BioMarine ASA's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Aker BioMarine ASA's Equity-to-Asset Distribution in the Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Aker BioMarine ASA's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where Aker BioMarine ASA's Equity-to-Asset falls into.
Aker BioMarine ASA Equity-to-Asset Calculation
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
Aker BioMarine ASA's Equity to Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
Aker BioMarine ASA Equity-to-Asset Related Terms
Thank you for viewing the detailed overview of Aker BioMarine ASA's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.
Aker BioMarine ASA (OSL:AKBM) Business Description
Aker BioMarine ASA is a supplier of krill-derived products, with a fully owned supply chain. The operations of the company span from harvesting krill in Antarctica with vessels owned by the company including distribution worldwide from Uruguay, and further processing of the krill into oil products in the United States. The segments of the company include 1) The Ingredients segment involves offshore harvesting and production, logistical operations, and onshore manufacturing and sales of krill-derived products. 2) The Brands segment focuses on human consumer goods, with Lang Pharma Nutrition (Lang) and Epion as its two main components. Lang produces and distributes private-label vitamins and supplements to retailers in the U.S. market and Epion is Aker BioMarine's consumer brand company.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
OSL:AKBM has been successfully added to your 